Try our mobile app

BioMarin to Participate in Jefferies London Healthcare Conference on November 21, 2019

Published: 2019-11-12 13:30:00 ET
<<<  go to BMRN company page

SAN RAFAEL, Calif., Nov. 12, 2019 /PRNewswire/ -- BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will present at the Jefferies London Healthcare Conference on November 21, 2019 at 1:20pm GMT/8:20am ET. To access the live webcast, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following each event.

About BioMarinBioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of seven commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

 

Cision View original content to download multimedia:http://www.prnewswire.com/news-releases/biomarin-to-participate-in-jefferies-london-healthcare-conference-on-november-21-2019-300956123.html

SOURCE BioMarin Pharmaceutical Inc.